• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PENUMBRA, INC. PENUMBRA SYSTEM 3MAX REPERFUSION CATHETER; NRY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PENUMBRA, INC. PENUMBRA SYSTEM 3MAX REPERFUSION CATHETER; NRY Back to Search Results
Model Number 3MAXC-B
Device Problem Break (1069)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/04/2022
Event Type  malfunction  
Event Description
The patient was undergoing a thrombectomy procedure in the right middle cerebral artery (mca) using a penumbra system 3max reperfusion catheter (3maxc), a neuron max 6f 088 long sheath (neuron max), a penumbra system red 72 reperfusion catheter (red72) and a non-penumbra guidewire.It was noted that the patient¿s anatomy was tortuous.During the procedure, the physician completed two passes using the red72.During the third pass, the physician advanced the red72 to the face of the clot with aspiration and then removed the 3maxc.Upon removal of the 3maxc, it was noticed that the distal part of the 3maxc was missing.The red72 appeared to be kinked on the fluoroscopy.Therefore, the red72 was also removed from the patient.The broken piece of the 3maxc was found inside the red72; however, the red72 was not damaged.Subsequently, the physician used a syringe to remove the broken piece of 3maxc on the back table.Then, the physician completed two additional passes using a new 3maxc, the same red72 and the same neuron max.The thrombectomy was not successful due to low tici score; however, this was not due to any penumbra devices used in the procedure.There was no report of an adverse effect to the patient.
 
Manufacturer Narrative
The device has been returned and the investigation results are pending.A follow up mdr will be submitted upon completion of the device investigation.
 
Manufacturer Narrative
Evaluation of the returned 3maxc confirmed that the catheter was fractured.Evaluation revealed stretching at the fractured location.If the 3maxc is forcefully retracted against resistance, damage such as stretching and subsequent fracture may occur.The root cause of resistance could not be determined.Penumbra catheters are visually inspected during in-process inspection and during quality inspection after manufacturing.The manufacturing records for this lot were reviewed and did not reveal any outstanding discrepancies, design, or quality concerns.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PENUMBRA SYSTEM 3MAX REPERFUSION CATHETER
Type of Device
NRY
Manufacturer (Section D)
PENUMBRA, INC.
one penumbra place
alameda CA 94502
Manufacturer Contact
veronica farris
one penumbra place
alameda, CA 94502
5107483200
MDR Report Key13404969
MDR Text Key287421306
Report Number3005168196-2022-00032
Device Sequence Number1
Product Code NRY
UDI-Device Identifier00814548019956
UDI-Public00814548019956
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K160449
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/01/2005,02/02/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/23/2024
Device Model Number3MAXC-B
Device Catalogue Number3MAXC
Device Lot NumberF108621
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/14/2022
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Report Sent to FDA01/01/2005
Date Report to Manufacturer01/10/2005
Initial Date Manufacturer Received 01/04/2022
Initial Date FDA Received01/31/2022
Supplement Dates Manufacturer Received02/01/2022
Supplement Dates FDA Received02/02/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/24/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-